Compare GCTS & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GCTS | INFU |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.4M | 197.0M |
| IPO Year | 2021 | 2005 |
| Metric | GCTS | INFU |
|---|---|---|
| Price | $1.92 | $12.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $3.50 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 2.3M | 156.8K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.20 |
| Revenue | $2,866,000.00 | ★ $143,436,000.00 |
| Revenue This Year | $1,052.30 | $3.20 |
| Revenue Next Year | $140.29 | $7.31 |
| P/E Ratio | ★ N/A | $60.20 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $0.96 | $7.29 |
| 52 Week High | $3.93 | $12.97 |
| Indicator | GCTS | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 61.07 |
| Support Level | $1.73 | $8.75 |
| Resistance Level | $2.69 | $12.97 |
| Average True Range (ATR) | 0.15 | 0.35 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 9.88 | 33.33 |
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness. Geographically, operates in South Korea and the United States, with maximum revenue from the USA.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.